Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria

A Simons, K Alhanout, RE Duval - Microorganisms, 2020 - mdpi.com
Currently, the emergence and ongoing dissemination of antimicrobial resistance among
bacteria are critical health and economic issue, leading to increased rates of morbidity and …

Molecular mechanisms related to colistin resistance in Enterobacteriaceae

Z Aghapour, P Gholizadeh, K Ganbarov… - Infection and drug …, 2019 - Taylor & Francis
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative
bacteria. It is used currently as a last-line drug for infections due to severe Gram-negative …

The surgical infection society revised guidelines on the management of intra-abdominal infection

JE Mazuski, JM Tessier, AK May, RG Sawyer… - Surgical …, 2017 - liebertpub.com
Background: Previous evidence-based guidelines on the management of intra-abdominal
infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and …

Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis

MC Brouwer, AR Tunkel… - Clinical microbiology …, 2010 - Am Soc Microbiol
The epidemiology of bacterial meningitis has changed as a result of the widespread use of
conjugate vaccines and preventive antimicrobial treatment of pregnant women. Given the …

The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how

I Karaiskos, S Lagou, K Pontikis, V Rapti… - Frontiers in public …, 2019 - frontiersin.org
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses
significant challenges in the treatment of healthcare associated infections. An important …

Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria

H Nikaido, JM Pagès - FEMS microbiology reviews, 2012 - academic.oup.com
Antibiotic resistance mechanisms reported in Gram-negative bacteria are causing a
worldwide health problem. The continuous dissemination of 'multidrug-resistant'(MDR) …

Colistin: an update on the antibiotic of the 21st century

S Biswas, JM Brunel, JC Dubus… - Expert review of anti …, 2012 - Taylor & Francis
The emergence of multidrug-resistant Gram-negative bacteria that cause nosocomial
infections is a growing problem worldwide. Colistin was first introduced in 1952 and was …

Strategies to minimize antibiotic resistance

CR Lee, IH Cho, BC Jeong, SH Lee - International journal of …, 2013 - mdpi.com
Antibiotic resistance can be reduced by using antibiotics prudently based on guidelines of
antimicrobial stewardship programs (ASPs) and various data such as pharmacokinetic (PK) …

Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options

E Cerceo, SB Deitelzweig, BM Sherman… - Microbial Drug …, 2016 - liebertpub.com
The increasing prevalence of infections due to multidrug-resistant (MDR) gram-negative
bacteria constitutes a serious threat to global public health due to the limited treatment …

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

I Karaiskos, H Giamarellou - Expert opinion on pharmacotherapy, 2014 - Taylor & Francis
Introduction: In the era of multidrug-resistant, extensively drug-resistant (XDR) and even
pandrug-resistant Gram-negative microorganisms, the medical community is facing the …